Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lopez

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|April 28, 2020
Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic ModelAn Van den Bergh, Jan Snoeys, Loeckie De Zwart, et al.
Research Involvement and Engagement|August 29, 2023
Patient and public involvement to inform priorities and practice for research using existing healthcare data for children's and young people's cancersNicola F Hughes, Lorna A Fern, Angela Polanco, et al.
Frontiers in Oncology|April 12, 2024
Corrigendum: Cancer data quality and harmonization in Europe: The experience of the BENCHISTA Project - International Benchmarking of Childhood Cancer Survival by StageAngela Lopez-Cortes, Fabio Didonè, Laura Botta, et al.
Education and Information Technologies|August 22, 2022
Impact of digital technologies upon teaching and learning in higher education in Latin America: an outlook on the reach, barriers, and bottlenecksKingsley Okoye, Haruna Hussein, Arturo Arrona-Palacios, et al.
Frontiers in Oncology|September 7, 2023
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project - international benchmarking of childhood cancer survival by stageAngela Lopez-Cortes, Fabio Didonè, Laura Botta, et al.
Cancer Chemotherapy and Pharmacology|April 2, 2022
Efficacy and safety exposure-response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN studyHuybrecht T'jollyn, Oliver Ackaert, Caly Chien, et al.
Pediatric Blood & Cancer|January 16, 2026
Survival for Children Diagnosed With Wilms Tumour (2012-2022) Registered in the UK and Ireland Improving Population Outcomes for Renal Tumours of Childhood (IMPORT) StudyNaomi Ssenyonga, Angela Lopez-Cortes, Reem Al-Saadi, et al.
Journal of Medicinal Chemistry|August 14, 2008
Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1Nassima Oumata, Karima Bettayeb, Yoan Ferandin, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort studyLaura Botta, Fabio Didonè, Angela Lopez-Cortes, et al.
Prostate International|January 11, 2021
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 studyHiroji Uemura, Takefumi Satoh, Hideyasu Tsumura, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|April 28, 2020
Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic ModelAn Van den Bergh, Jan Snoeys, Loeckie De Zwart, et al.
Research Involvement and Engagement|August 29, 2023
Patient and public involvement to inform priorities and practice for research using existing healthcare data for children's and young people's cancersNicola F Hughes, Lorna A Fern, Angela Polanco, et al.
Frontiers in Oncology|April 12, 2024
Corrigendum: Cancer data quality and harmonization in Europe: The experience of the BENCHISTA Project - International Benchmarking of Childhood Cancer Survival by StageAngela Lopez-Cortes, Fabio Didonè, Laura Botta, et al.
Education and Information Technologies|August 22, 2022
Impact of digital technologies upon teaching and learning in higher education in Latin America: an outlook on the reach, barriers, and bottlenecksKingsley Okoye, Haruna Hussein, Arturo Arrona-Palacios, et al.
Frontiers in Oncology|September 7, 2023
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project - international benchmarking of childhood cancer survival by stageAngela Lopez-Cortes, Fabio Didonè, Laura Botta, et al.
Cancer Chemotherapy and Pharmacology|April 2, 2022
Efficacy and safety exposure-response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN studyHuybrecht T'jollyn, Oliver Ackaert, Caly Chien, et al.
Pediatric Blood & Cancer|January 16, 2026
Survival for Children Diagnosed With Wilms Tumour (2012-2022) Registered in the UK and Ireland Improving Population Outcomes for Renal Tumours of Childhood (IMPORT) StudyNaomi Ssenyonga, Angela Lopez-Cortes, Reem Al-Saadi, et al.
Journal of Medicinal Chemistry|August 14, 2008
Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1Nassima Oumata, Karima Bettayeb, Yoan Ferandin, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort studyLaura Botta, Fabio Didonè, Angela Lopez-Cortes, et al.
Prostate International|January 11, 2021
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 studyHiroji Uemura, Takefumi Satoh, Hideyasu Tsumura, et al.
Pageof 8